Latest News

Psychedelic Stock News: Global Wellness (CSE: GWS) Readies for First Clinical Trial

Vancouver, Canada, and Rehovot, Israel – May 12, 2022 (Newsfile Corp.) (Investorideas.com Newswire) Global Wellness Strategies Inc. (CSE: GWS) (OTCQB: GWSFF) (FSE: O3X) announces Shanti Therapeutics MDMA Clinical Trial Update.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Latest News